Jaffee EM - Search Results

1

Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials.

Jaffee EM, Schutte M, Gossett J, Morsberger LA, Adler AJ, Thomas M, Greten TF, Hruban RH, Yeo CJ, Griffin CA. Jaffee EM, et al. Cancer J Sci Am. 1998 May-Jun;4(3):194-203. Cancer J Sci Am. 1998. PMID: 9612602

2

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. Huang AY, et al. Science. 1994 May 13;264(5161):961-5. doi: 10.1126/science.7513904. Science. 1994. PMID: 7513904

3

Consistent chromosome abnormalities in adenocarcinoma of the pancreas.

Griffin CA, Hruban RH, Morsberger LA, Ellingham T, Long PP, Jaffee EM, Hauda KM, Bohlander SK, Yeo CJ. Griffin CA, et al. Among authors: jaffee em. Cancer Res. 1995 Jun 1;55(11):2394-9. Cancer Res. 1995. PMID: 7757992

4

Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design.

Golumbek PT, Azhari R, Jaffee EM, Levitsky HI, Lazenby A, Leong K, Pardoll DM. Golumbek PT, et al. Among authors: jaffee em. Cancer Res. 1993 Dec 15;53(24):5841-4. Cancer Res. 1993. PMID: 8261390

5

Demonstration of a rational strategy for human prostate cancer gene therapy.

Sanda MG, Ayyagari SR, Jaffee EM, Epstein JI, Clift SL, Cohen LK, Dranoff G, Pardoll DM, Mulligan RC, Simons JW. Sanda MG, et al. Among authors: jaffee em. J Urol. 1994 Mar;151(3):622-8. doi: 10.1016/s0022-5347(17)35032-2. J Urol. 1994. PMID: 8308972 Free article.

6

High efficiency gene transfer into primary human tumor explants without cell selection.

Jaffee EM, Dranoff G, Cohen LK, Hauda KM, Clift S, Marshall FF, Mulligan RC, Pardoll DM. Jaffee EM, et al. Cancer Res. 1993 May 15;53(10 Suppl):2221-6. Cancer Res. 1993. PMID: 8485707

7

Use of murine models of cytokine-secreting tumor vaccines to study feasibility and toxicity issues critical to designing clinical trials.

Jaffee EM, Lazenby A, Meurer J, Marshall F, Hauda KM, Counts C, Hurwitz H, Simons JW, Levitsky HI, Pardoll DM. Jaffee EM, et al. J Immunother Emphasis Tumor Immunol. 1995 Jul;18(1):1-9. doi: 10.1097/00002371-199507000-00001. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8535565 No abstract available.

8

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.

Huang AY, Gulden PH, Woods AS, Thomas MC, Tong CD, Wang W, Engelhard VH, Pasternack G, Cotter R, Hunt D, Pardoll DM, Jaffee EM. Huang AY, et al. Among authors: jaffee em. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9730-5. doi: 10.1073/pnas.93.18.9730. Proc Natl Acad Sci U S A. 1996. PMID: 8790399 Free PMC article.

9

Enhanced immune priming with spatial distribution of paracrine cytokine vaccines.

Jaffee EM, Thomas MC, Huang AY, Hauda KM, Levitsky HI, Pardoll DM. Jaffee EM, et al. J Immunother Emphasis Tumor Immunol. 1996 May;19(3):176-83. doi: 10.1097/00002371-199605000-00002. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8811492

10

Systemic and local paracrine cytokine therapies using transduced tumor cells are synergistic in treating intracranial tumors.

Thompson RC, Pardoll DM, Jaffee EM, Ewend MG, Thomas MC, Tyler BM, Brem H. Thompson RC, et al. Among authors: jaffee em. J Immunother Emphasis Tumor Immunol. 1996 Nov;19(6):405-13. doi: 10.1097/00002371-199611000-00004. J Immunother Emphasis Tumor Immunol. 1996. PMID: 9041459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters